Gary Gilliland (1957-1961), Susan Kaiser (1963-1967), Kelly Cobb (1983-1987), Larry Sanchez (1964-1968), Matt Davis (1987-1991), Dotty Sumner (1974-1978)
Retzlaffs ire was echoed by Dr. Gary Gilliland, president and director of the Fred Hutchinson Cancer Research Center in Seattle, which received more NIH funding in 2017 than any other cancer center in the country.
Date: Mar 16, 2017
Category: Health
Source: Google
Fred Hutch joins nation's cancer centers in endorsing HPV vaccination
with the virus, which means, essentially, people who are not yet sexually active, said Dr. Gary Gilliland, president and director of Fred Hutch, whose researchers played a pivotal role in both discovering HPVs association with cancer and paving the way for the development of the vaccine.
ring his nearly five-year tenure are numerous, according to his peers. His influence was felt at Fred Hutchinson Cancer Research Center, in particular for his stewardship of important research programs during a difficult financial period, said Fred Hutch President and Director Dr. D. Gary Gilliland.
Date: Mar 05, 2015
Category: Health
Source: Google
Hutchinson Cancer Research Center Names Gary Gilliland as new director
Gary Gilliland comes to Fred Hutch from the University of Pennsylvania's Perelman School of Medicine where he was the vice-president of precision medicine. Before that he was an executive at Merck Research Laboratories. Also, he has spent more than 20 years at Harvard Medical School where he was a p
Date: Nov 21, 2014
Category: Health
Source: Google
Genetic expert Gary Gilliland named President of Fred Hutch
Chair of Fred Hutchs board of trustees, Paula Reynolds confirms that Gilliland was the ideal candidate considering his exceptional discoveries in science and his leadership experience that has been very diverse.Gary Gilliland will take up the reins as director of Fred Hutch on Jan. 2. The acting d
Date: Nov 21, 2014
Category: Health
Source: Google
New 'Hutch' Director Aims To Push Toward Cancer Cures Based On The ...
This morning, the Fred Hutchinson Cancer Research Center in Seattle, a hotbed for the development of new treatments that harness the immune system against cancer, is announcing that it has hired former Merck cancer research boss Gary Gilliland as its next director.
Dr. D. Gary Gilliland, a physician-scientist with a background in academic medicine and the pharmaceutical industry, will take the helm as Fred Hutchinsons new leader on Jan. 2, the center said in a prepared statement.
Date: Nov 20, 2014
Category: Health
Source: Google
What Makes a Breakthrough Cancer Drug in the Eyes of the FDA
"We have unfettered access to higher-level officials at the FDA," said Gary Gilliland, a Merck senior vice president and oncology franchise head. The agency has provided guidance on Merck's clinical development program with an aim toward submitting the drug for approval as quickly as possible.